Ann Marie Navar Boggan, Michael J. Pencina
Concerns over bias in clinical trial reporting have stimulated calls for more open data sharing.1 In response, multiple pharmaceutical companies have created mechanisms for investigators to access patient-level clinical trials data. However, if and how these shared clinical trial data are being used is unknown.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados